Search Results

You are looking at 1 - 10 of 763 items for :

  • User-accessible content x
Clear All
Full access

David Y. T. Chen and Robert G. Uzzo

Edited by Kerrin G. Robinson

. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients . Ann Surg 1999 ; 230 : 1 – 8 . 30 Dupuy DE Zagoria RJ Akerley W . Percutaneous radiofrequency ablation of malignancies in the lung . AJR

Full access

Cletus A. Arciero and Elin R. Sigurdson

comparison of radio-frequency thermal ablation versus percutaneous ethanol injection . Radiology 2003 ; 228 : 235 – 240 . 36. Livraghi T Bolondi L Lazzaroni S . Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in

Full access

Michel Kahaleh

Endoscopic Biliary Drainage “From an endoscopy standpoint, knowing the different segments of the liver is crucial in terms of being able to provide biliary decompression,” declared Dr. Kahaleh. “Everything we do is based on symptoms and imaging,” he added

Full access

Thomas B. Nealis, Kay Washington and Rajesh N. Keswani

's esophagus cases to reduce the risk of synchronous or metachronous lesions. Complete remission ranges from 94% to 97% for patients undergoing CBE-EMR for HGD or intramucosal adenocarcinoma, with focal radiofrequency ablation used in some cases. 54 However

Full access

Janice S. Kwon, Gary Pansegrau, Melica Nourmoussavi, Geoffrey L. Hammond and Mark S. Carey

use in premenopausal women, there are long-term risks of ovarian ablation (OA), which is a necessary additional intervention in women who still have ovarian function. A recent study found that OA preceeding an AI (OA/AI) was more costly and less

Full access

Robert E. Glasgow, David H. Ilson, James A. Hayman, Hans Gerdes, Mary F. Mulcahy and Jaffer A. Ajani

, preferably, endoscopic mucosal resection (EMR) biopsy of the lesion to evaluate for submucosal extension. For patients with a T1aN0M0 tumor, treatment options include EMR with negative pathologic margins and ablation of at-risk adjacent mucosa or

Full access

Joseph M. Herman, John P. Hoffman, Sarah P. Thayer and Robert A. Wolff

. Fourth, image-guided percutaneous radiofrequency ablation (RFA) and laparoscopically assisted RFA may allow for management of limited metastatic disease and spare patients the toxicity associated with ongoing cytotoxic chemotherapy. Lastly, the

Full access

Larry K. Kvols, Kiran K. Turaga, Jonathan Strosberg and Junsung Choi

: 1029 – 1035 . 50 Hellman P Ladjevardi S Skogseid B . Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors . World J Surg 2002 ; 26 : 1052 – 1056 . 51 Giovannini M . Percutaneous alcohol

Full access

Margaret A. Tempero

disease, and (3) adjuvant therapy with modified FOLFIRINOX (leucovorin/5-FU/irinotecan/oxaliplatin) for patients who are able to tolerate it. Presenting these updates was Margaret A. Tempero, MD, Professor of Medicine, and Director of the UCSF Pancreas

Full access

Noam VanderWalde, Reshma Jagsi, Efrat Dotan, Joel Baumgartner, Ilene S. Browner, Peggy Burhenn, Harvey Jay Cohen, Barish H. Edil, Beatrice Edwards, Martine Extermann, Apar Kishor P. Ganti, Cary Gross, Joleen Hubbard, Nancy L. Keating, Beatriz Korc-Grodzicki, June M. McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O'Connor, Hope S. Rugo, Randall W. Rupper, Dale Shepard, Rebecca A. Silliman, Derek L. Stirewalt, William P. Tew, Louise C. Walter, Tanya Wildes, Mary Anne Bergman, Hema Sundar and Arti Hurria

this activity, participants will be able to: Integrate into professional practice the updates to NCCN Guidelines for Older Adult Oncology Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Older Adult